HB Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.93M | Sell |
27,650
-18,913
| -41% | -$1.32M | 0.02% | 374 |
|
|
2025
Q1 | $3.42M | Buy |
46,563
+14,390
| +45% | +$1.06M | 0.03% | 282 |
|
|
2024
Q4 | $2.11M | Sell |
32,173
-89
| -0.3% | -$5.83K | 0.02% | 275 |
|
|
2024
Q3 | $2.51M | Buy |
32,262
+2,102
| +7% | +$164K | 0.03% | 239 |
|
|
2024
Q2 | $2.35M | Buy |
30,160
+1,012
| +3% | +$78.9K | 0.03% | 239 |
|
|
2024
Q1 | $1.97M | Buy |
29,148
+694
| +2% | +$47K | 0.02% | 248 |
|
|
2023
Q4 | $1.92M | Buy |
28,454
+354
| +1% | +$23.8K | 0.03% | 234 |
|
|
2023
Q3 | $1.9M | Buy |
28,100
+3,722
| +15% | +$252K | 0.03% | 214 |
|
|
2023
Q2 | $1.74M | Buy |
24,378
+33
| +0.1% | +$2.36K | 0.03% | 222 |
|
|
2023
Q1 | $1.69M | Sell |
24,345
-83
| -0.3% | -$5.76K | 0.03% | 218 |
|
|
2022
Q4 | $1.66M | Buy |
24,428
+15,694
| +180% | +$1.06M | 0.03% | 222 |
|
|
2022
Q3 | $479K | Buy |
8,734
+626
| +8% | +$34.3K | 0.01% | 342 |
|
|
2022
Q2 | $536K | Sell |
8,108
-758
| -9% | -$50.1K | 0.01% | 333 |
|
|
2022
Q1 | $588K | Buy |
8,866
+2,923
| +49% | +$194K | 0.01% | 320 |
|
|
2021
Q4 | $346K | Buy |
+5,943
| New | +$346K | 0.01% | 363 |
|